Biote Corp. Class A Common Stock

$2.350
USD
Last updated on --.
24h volume76.98K
24h highest2.3800 USD
24h lowest2.3300 USD
24h Price movement-0.42%

BTMD recent prices

24 Hours
-0.42%-$0.01
30 days
+12.20%+$0.255
60 days
+57.38%+$0.855
90 days
+31.01%+$0.555

Key data

Previous close2.3600 USD
Market cap60.66M USD
Volume76.98K
P/E ratio3.890000
Dividend yield (TTM)0.02%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)0.51000 USD
Net income (FY)18.43M USD
Revenue (FY)188.16M USD
Last report dateMay 11, 2026

About Biote Corp. Class A Common Stock

MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
HeadquartersIRVING
Employees (FY)223.00
Revenue per employee (FY)843.78K USD
Net income per employee (FY)82.66K USD
Listed onNasdaq
Official website

BTMD conversion tables

BTMDBTMD
USDUSD
0.5 BTMD1.175 USD
1 BTMD2.350 USD
5 BTMD11.75 USD
10 BTMD23.5 USD
USDUSD
BTMDBTMD
0.5 USD0.21277 BTMD
1 USD0.42553 BTMD
5 USD2.127 BTMD
10 USD4.255 BTMD

FAQ

BTMD is trading at $2.350, -0.42% over the last 24 hours. Track live moves on the price chart at the top of this page.
The BTMD stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. BTMD is currently trading at $2.350, -0.42% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on BTMD price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. BTMD's P/E ratio is currently 3.890000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from BTMD; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against BTMD's historical range and other companies in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector.
Biote Corp. Class A Common Stock's market cap is currently 60.66M USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume76.98K
24h highest2.3800 USD
24h lowest2.3300 USD
24h Price movement-0.42%
BTMDBTMD
USDUSD
Start trade with BTMD Perpetual